— Know what they know.
Not Investment Advice

CVSI OTC

CV Sciences, Inc.
1W: -6.6% 1M: -33.9% 3M: -37.6% YTD: -80.0% 1Y: -74.5% 3Y: -73.3% 5Y: -95.2%
$0.01
-0.00 (-5.41%)
 
Weekly Expected Move ±21.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · $2.6M mcap · 188M float · 0.355% daily turnover · Short 34% of daily vol

Balance Sheet Trends

Total Assets
$7M -12.2% ▼
5Y CAGR: -25.6%
Total Liabilities
$5M -10.4% ▼
5Y CAGR: -22.3%
Shareholders Equity
$1M -18.2% ▼
5Y CAGR: -33.4%
Cash & Investments
$278K -38.8% ▼
5Y CAGR: -41.4%
Total Debt
$2M +106.5% ▲
5Y CAGR: -27.0%
Net Debt
$1M +309.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1M$611K$1M$454K$278K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1M$611K$1M$454K$278K
Net Receivables$2M$766K$431K$522K$402K
Inventory$9M$7M$6M$5M$4M
Other Current Assets$2M$3M$535K$370K$366K
Total Current Assets$14M$11M$8M$6M$5M
Property, Plant & Equip.$2M$850K$546K$493K$691K
Goodwill & Intangibles$1M$251K$420K$1M$1M
Long-Term Investments-$19M-$18M$0$0$0
Other Non-Current Assets$678K$505K$296K$127K$47K
Total Non-Current Assets$4M$2M$18M$2M$2M
Total Assets$18M$13M$26M$8M$7M
— Liabilities —
Accounts Payable$3M$2M$2M$2M$1M
Short-Term Debt$922K$1M$254K$677K$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$7M$7M$2M$1M$2M
Total Current Liabilities$14M$13M$6M$6M$5M
Long-Term Debt$0$0$0$0$100K
Other Non-Current Liab.$0$0$105K$0$387K
Total Non-Current Liabilities$62K$199K$17M$23K$494K
Total Liabilities$15M$14M$23M$6M$5M
— Equity —
Common Stock$11K$15K$16K$18K$18K
Retained Earnings-$79M-$88M-$85M-$87M-$88M
Accumulated OCI-$0-$0$10K-$15K$59K
Total Stockholders Equity$4M-$777K$3M$2M$1M
Total Liabilities & Equity$18M$13M$26M$8M$7M
— Key Metrics —
Total Debt$922K$2M$442K$779K$2M
Net Debt-$453K$917K-$875K$325K$1M
Total Investments-$19M-$18M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms